BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Spectranetics Corporation (SPNC) to Participate in the 24th Annual Piper Jaffray Healthcare Conference


11/19/2012 11:03:11 AM

COLORADO SPRINGS, Colo., Nov. 16, 2012 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (SPNC) today announced that it will participate in the 24th Annual Piper Jaffray Healthcare Conference being held November 27 - 28, 2012 in New York City.

Scott Drake, Spectranetics' Chief Executive Officer, and Guy Childs, Spectranetics' Chief Financial Officer, are scheduled to host an investor discussion at 12:00 p.m. Eastern time on Wednesday, November 28th. Scott Drake and Guy Childs will also be hosting investor meetings throughout the same day. Interested parties can access a live audio webcast of the investor discussion at http://www.spectranetics.com. An archived version of the webcast will be available on the website for 30 days.

About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in more than 40 countries and are used to treat arterial blockages in the heart and legs, as well as the removal of pacemaker and defibrillator leads.

The Company's Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration and thrombectomy catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads.

For more information, visit www.spectranetics.com.

Contact:

COMPANY CONTACT

The Spectranetics Corporation

Guy Childs, Chief Financial Officer

(719) 633-8333

INVESTOR CONTACTS

Westwicke Partners

Lynn Pieper or Nicole Hellendoorn

(415) 202-5678

lynn.pieper@westwicke.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES